The SEC filed charges against a Massachusetts businessman for misusing investment funds intended for two pharmaceutical development companies.
Among other worrisome findings, 23% of non-listed ECGs disclosed that they were shell companies.
Jeffrey Eberwein and Charles Gillman allegedly failed to properly disclose material information about their activist efforts involving five companies.
More investors say they trust auditors, financial analysts, and rating agencies, according to a new survey.
Despite weighty challenges, the fast-emerging legal marijuana industry invites a ‘Green Rush’ of interest.
Are data-security and privacy issues causing uncertainty among the search giant's stakeholders?
If companies don't recognize and address water-scarcity issues, risks will accumulate and could eventually threaten entire businesses.
